Relevant bibliographies by topics / Fatty liver disease

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Fatty liver disease'

Author: Grafiati
Published: 4 June 2021
Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Fatty liver disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Fatty liver disease"

1

Fujioka, Kazumi. "Link between Non-Alcoholic Fatty Liver Disease and Hypertension: Non-Alcoholic Fatty Liver Disease as a Multisystem Disease." International Journal of Clinical Case Reports and Reviews 10, no. 5 (2022): 01–04. http://dx.doi.org/10.31579/2690-4861/203.

Full text
Abstract:
The prevalence and incidence of non-alcoholic fatty liver disease (NAFLD) is increasing due to the epidemics of obesity and type 2 diabetes mellitus (T2DM). Many studies provided the evidence of the decreased flow-mediated vasodilation (FMD), increased carotid intima-media thickness (IMT), and increased brachial ankle pulse wave velocity (baPWV) in patients with NAFLD. Recently, a link between NAFLD and hypertension along with new genetic expression, ADIPOQ C11377G and AGTR1 has been shown. It is putative that NAFLD may induce systemic inflammation, insulin resistance, oxidative stress, and in
APA, Harvard, Vancouver, ISO, and other styles
2

L Pathan, Fayaj. "Nonalcoholic Fatty Liver Disease (NAFLD) A Chronic Liver Disease." Acta Scientifci Nutritional Health 4, no. 1 (2019): 58. http://dx.doi.org/10.31080/asnh.2020.04.nonalcoholic-fatty-liver-disease-nafld-a-chronic-liver-disease.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mirzakarimova, Farida, Svetlana Kaleda, Natalia Polikarpova, and Abdumurad Babadjanov. "NONALCOHOLIC FATTY LIVER DISEASE -SOME ASPECTS OF PREVENTION." UZBEK MEDICAL JOURNAL 2, no. 2 (2021): 15–24. http://dx.doi.org/10.26739/2181-0664-2021-2-3.

Full text
Abstract:
Nowadays, NAFLD is considered one of the leading causes of chronic liver diseases globally.This is probably becausea patient with NAFLD usually had more severe diseases -diabetes mellitus type 2 (DM-2), metabolic syndrome, etc. On the one hand, after it was established that insulin resistance underlies these metabolic diseases and, on the other hand, that compensationfor these conditions does not eliminate NAFLD, and the presence of NAFLD worsens the course of the underlying disease, interest in its study increased significantly. The development of NAFLD is increasingly associated with the hyp
APA, Harvard, Vancouver, ISO, and other styles
4

kadhium, Athraa fouad. "Fighting Fatty Liver Disease: Pathogenesis and Therapeutic Approaches." International Journal of Medical Science and Dental Health 10, no. 08 (2024): 27–38. http://dx.doi.org/10.55640/ijmsdh-10-08-03.

Full text
Abstract:
FLD is a burgeoning international ailment closely associated with the increasing rates of obesity, type II diabetes mellitus and physical inactivity. This review focuses on the various aspects of FLD pathophysiology including genetic susceptibility, metabolic disturbances, inflammation, oxidative stress, and environmental factors. Diagnostic tests can be simple and non-invasive such as imaging and biomarkers and can be relatively invasive, such as liver biopsies. Currently the treatment focus is made on drug and surgical interventions with lifestyle changes, and besides, gene and stem cell the
APA, Harvard, Vancouver, ISO, and other styles
5

Babaalizadeh, Behina, Maryam Bahmanyar, Mohammad Hassan Meshkibaf, and Behnoosh Miladpour. "Fatty Liver, Developing Factors and the Outcomes." International Journal of Forensic Research 5, no. 1 (2024): 192–202. http://dx.doi.org/10.33140/ijfr.05.01.01.

Full text
Abstract:
Fatty liver has grown increasingly in recent decades. Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States with a prevalence of 30% and the leading cause of liver disease with a mortality rate of 25.2% in the world. Fatty liver is divided into two types, alcoholic and non-alcoholic. It has been reported that 44% of NAFLD patients progress to nonalcoholic steatohepatitis (NASH) at the second biopsy, and in several countries, hepatocellular carcinoma is the most common disease. Unfortunately, no absolute cure has yet been found. Finding out
APA, Harvard, Vancouver, ISO, and other styles
6

Brody, Herb. "Fatty liver disease." Nature 551, no. 7681 (2017): S85. http://dx.doi.org/10.1038/d41586-017-06927-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sanyal, Arun. "Fatty Liver Disease." Seminars in Liver Disease 28, no. 04 (2008): 337. http://dx.doi.org/10.1055/s-0028-1091977.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Softic, Samir, and C. Ronald Kahn. "Fatty liver disease." European Journal of Gastroenterology & Hepatology 31, no. 1 (2019): 143. http://dx.doi.org/10.1097/meg.0000000000001279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Petts, Gemma, Kirsty Lloyd, and Robert Goldin. "Fatty liver disease." Diagnostic Histopathology 20, no. 3 (2014): 102–8. http://dx.doi.org/10.1016/j.mpdhp.2014.01.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hampton, Tracy. "Fatty Liver Disease." JAMA 305, no. 21 (2011): 2162. http://dx.doi.org/10.1001/jama.2011.724.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Fatty liver disease"

1

Bayard, Max, Jim Holt, and Eileen Boroughs. "Nonalcoholic Fatty Liver Disease." Digital Commons @ East Tennessee State University, 2006. https://dc.etsu.edu/etsu-works/6487.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bayard, Max, and Jim Holt. "Non-Alcoholic Fatty Liver Disease." Digital Commons @ East Tennessee State University, 2007. https://dc.etsu.edu/etsu-works/6495.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Levene, Adam Phillip. "Steatosis in non alcoholic fatty liver disease." Thesis, Imperial College London, 2012. http://hdl.handle.net/10044/1/9691.

Full text
Abstract:
Non-alcoholic fatty liver disease is the commonest cause of chronic liver disease in developed countries. The accurate assessment of steatosis is central to the diagnosis of non-alcoholic fatty liver disease. I compared the assessment of steatosis by histology, biochemical triglyceride assays, digital image analysis, with and without Oil Red-O staining, in mouse livers and human liver biopsies. In each case Oil Red-O digital image analysis was the most reliable technique for quantitating steatosis. I then investigated a potential, non-invasive technique for distinguishing steatosis from steato
APA, Harvard, Vancouver, ISO, and other styles
4

De, Alwis Nimantha M. W. "Mitochondrial dysfunction in non alcoholic fatty liver disease." Thesis, University of Newcastle Upon Tyne, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.493235.

Full text
Abstract:
Non Alcoholic fatty Liver disease (NAFLD) is the commonest chronic liver disease worldwide and is a spectrum which includes simple fatty liver (simple steatosis), non-alcoholic steatohepatitis (NASH) and cirrhosis. Simple steatosis is a benign condition but NASH may progress to liver fibrosis and cirrhosis. Why only some develop progressive disease is not known and maybe dependant on the pathophysiology.
APA, Harvard, Vancouver, ISO, and other styles
5

Fraser, Abigail. "Causes and consequences of nonalcoholic fatty liver disease." Thesis, University of Bristol, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.492651.

Full text
Abstract:
Nonalcoholic fatty liver disease (NAFLD) is characterized by the accumulation of fat in the liver with or without inflammation, fibrosis and cirrhosis, in the absence of substantial alcohol consumption. In this thesis, several potential causes of NAFLD from across the life course, have been investigated, as well as associations of NAFLD with major clinical outcomes. This was done using data from three population based studies: the British Women's Heart and Health Study, a prospective cohort of 4,286 British women ages 60-79; the Caerphilly Prospective Study, a cohort of 2,512 Welsh men ages 40
APA, Harvard, Vancouver, ISO, and other styles
6

Liu, Yang-Lin. "Genomic studies in non-alcoholic fatty liver disease." Thesis, University of Newcastle upon Tyne, 2017. http://hdl.handle.net/10443/3822.

Full text
Abstract:
Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum that spans simple steatosis, through steatohepatitis (NASH) to fibrosis and ultimately cirrhosis. NAFLD is characterised by substantial inter-patient variation in rate of progression and disease outcome: whilst up to 25% of the general population are at risk of progressive disease, only a minority experience associated liver-related morbidity. Inter-patient genetic variation and environment determine severity and progression of NAFLD. This thesis reports a series of studies examining the association of genetic variations in two g
APA, Harvard, Vancouver, ISO, and other styles
7

CADDEO, ANDREA MARCO. "The role of MBOAT7 on fatty liver disease." Doctoral thesis, Università degli Studi di Cagliari, 2021. http://hdl.handle.net/11584/345538.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Scorletti, Eleonora. "Effect of omega-3 fatty acids in non-alcoholic fatty liver disease." Thesis, University of Southampton, 2017. https://eprints.soton.ac.uk/422265/.

Full text
Abstract:
The first chapter (Introduction) of the thesis summarises the pathogenesis of NAFLD and its associated risk factors such as type 2 diabetes and cardiovascular disease. Moreover, it describes: a) the potential beneficial effects of long chain omega-3 fatty acid treatment [docosahexaenoic acid (DHA) plus eicosapentaenoic acid (EPA)] in NAFLD; b) the effect of genotypes patatin-like phospholipase domain-containing protein-3 (PNPLA3 I148M) and the transmembrane 6 superfamily member 2 protein (TM6SF2 E167K), on the level of DHA and EPA enrichment and end of study liver fat percentage after DHA+EPA
APA, Harvard, Vancouver, ISO, and other styles
9

Spanos, Christos. "Quantitative liver proteomics for biomarker discovery in non-alcoholic fatty liver disease." Thesis, University of Surrey, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.616323.

Full text
Abstract:
Non-alcoholic fatty liver disease (NAFLD) is now the most common liver disease worldwide. Given that NAFLD can progress from steatosis to non-alcoholic steatohepatitis (NASH), fibrosis and potentially hepatocellular carcinoma, early diagnosis and accurate disease staging are primary clinical concerns. Hypothesizing that a subset of liver proteins will exhibit differential expression in NAFLD and that these proteins may represent candidate disease biomarkers; the aims of this project were to use proteomics to identify differentially expressed proteins both in an in vitro and an in vivo model of
APA, Harvard, Vancouver, ISO, and other styles
10

Al-Serri, Ahmad E. O. F. O. "Genetic factors affecting progression of nonalcoholic fatty liver disease." Thesis, University of Newcastle Upon Tyne, 2011. http://hdl.handle.net/10443/1323.

Full text
Abstract:
Non-alcoholic fatty liver disease (NAFLD) ranges from steatosis to the more progressive form non-alcoholic steatohepatitis. Genetic factors may be important risk determinants for disease progression. This study aimed to assess association of polymorphisms in candidate genes with NAFLD severity and to investigate functional significance of selected polymorphisms Two approaches were used for association studies, case-control analysis on adults (n=351) with biopsy-proven NAFLD and transmission disequilibrium on family trios (n=71) with an index child with NAFLD. A total of 37 polymorphisms in 14
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Fatty liver disease"

1

C, Farrell Geoffrey, ed. Fatty liver disease: NASH and related disorders. Blackwell Pub., 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bugianesi, Elisabetta, ed. Non-Alcoholic Fatty Liver Disease. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-95828-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Farrell, Geoffrey C., Arthur J. McCullough, and Christopher P. Day, eds. Non-Alcoholic Fatty Liver Disease. Wiley-Blackwell, 2013. http://dx.doi.org/10.1002/9781118556153.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Taylor-Robinson, Simon D., and Roger Williams. Clinical dilemmas in non-alcoholic fatty liver disease. John Wiley & Sons Inc., 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Farrell, Geoffrey C., Arthur J. McCullough, and Christopher Paul Day. Non-alcoholic fatty liver disease: A practical guide. John Wiley & Sons, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Aguila, Marcia Barbosa. Hepatic insulin resistance and nonalcoholic fatty liver disease. Nova Science, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chalasani, Naga, and Gyongyi Szabo, eds. Alcoholic and Non-Alcoholic Fatty Liver Disease. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20538-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Trifan, Anca, Carol Stanciu, and Cristina Muzica, eds. Essentials of Non-Alcoholic Fatty Liver Disease. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-33548-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yoneda, Masato. Insulin resistance and nonalcoholic fatty liver disease (NAFLD) nonalcoholic steatohepatitis (NASH). Nova Science Publishers, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Williams, Roger, and Simon D. Taylor-Robinson, eds. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781118924938.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Fatty liver disease"

1

Desnick, Robert J., Orlando Guntinas-Lichius, George W. Padberg, et al. "Fatty Liver/Fatty Liver Disease." In Encyclopedia of Molecular Mechanisms of Disease. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_8716.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Beeman, Scott C., and Joel R. Garbow. "Fatty Liver Disease." In Imaging and Metabolism. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-61401-4_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Alisi, Anna, Melania Manco, Rita Devito, and Valerio Nobili. "Fatty Liver Disease." In Pediatric Obesity. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-60327-874-4_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mouleeswaran, K. S., Joy Varghese, and Mettu Srinivas Reddy. "Fatty Liver Disease." In Atlas of Basic Liver Histology for Practicing Clinicians and Pathologists. Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-99-5762-0_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chan, Anthony W. H., Alberto Quaglia, Beate Haugk, and Alastair Burt. "Fatty Liver Disease." In Atlas of Liver Pathology. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-9114-9_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Claudia, Della Corte, Antonella Mosca, Arianna Alterio, Donatella Comparcola, Francesca Ferretti, and Valerio Nobili. "Fatty Liver Disease." In Contemporary Endocrinology. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-68192-4_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Haddad, Nael N., Amandeep Singh, Mazyar Malakouti, and Naim Alkhouri. "Nonalcoholic Fatty Liver Disease." In Liver Disease. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-98506-0_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gawrieh, Samer. "Nonalcoholic Fatty Liver Disease." In Liver Disorders. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-30103-7_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Alazawi, William, and Gideon Hirschfield. "Nonalcoholic Fatty Liver Disease." In Liver Immunology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-51709-0_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Patel, Vaishali, and Arun J. Sanyal. "Nonalcoholic Fatty Liver Disease." In Liver Immunology. Springer International Publishing, 2013. http://dx.doi.org/10.1007/978-3-319-02096-9_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Fatty liver disease"

1

Naserameri, Mohammad, Kavian Amirmozafarisabet, and Meisam Namazi. "Enhancing Fatty Liver Disease Diagnosis Using Deep from Ultrasound Images." In 2025 IEEE 6th International Conference on Image Processing, Applications and Systems (IPAS). IEEE, 2025. https://doi.org/10.1109/ipas63548.2025.10924570.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sri, P. Navya, G. Kranthi Kumar, Y. Hari Priya, and G. Pranav Chowdary. "Categorization of Non-Alcoholic Fatty Liver Disease Using XG-Boost." In 2024 International Conference on Intelligent Computing and Emerging Communication Technologies (ICEC). IEEE, 2024. https://doi.org/10.1109/icec59683.2024.10837138.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

R, Geetha, D. Jenila Rani, and K. Anbarasu. "Applying Deep Learning Methods to Non-Alcoholic Fatty Liver Disease Management." In 2024 5th International Conference on Circuits, Control, Communication and Computing (I4C). IEEE, 2024. http://dx.doi.org/10.1109/i4c62240.2024.10748435.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ali, Ayman, Ahmed Ashraf, and Kamel Rahouma. "Exploring Explainable Machine Learning in Early Liver Disease Detection: Insights from Fatty Liver and Hepatitis B." In 2024 6th Novel Intelligent and Leading Emerging Sciences Conference (NILES). IEEE, 2024. http://dx.doi.org/10.1109/niles63360.2024.10753181.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zheng, Yijiang, Zhuoxin Long, Ruting Cheng, et al. "Predicting Nonalcoholic Fatty Liver Disease in Obese Populations with 3D Body Scans." In 2024 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2024. https://doi.org/10.1109/embc53108.2024.10781798.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Koppula, Anil Kumar, and Sai Sudha Gadde. "A Systematic Review of Deep Learning Algorithms for Non-Alcoholic Fatty Liver Disease." In 2025 Third International Conference on Augmented Intelligence and Sustainable Systems (ICAISS). IEEE, 2025. https://doi.org/10.1109/icaiss61471.2025.11041809.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mathur, Siddharth, Priyansh Karodi, and Ritesh Dhanare. "Fatty Liver Disease Prediction Through Machine Learning." In 2024 3rd International Conference on Sentiment Analysis and Deep Learning (ICSADL). IEEE, 2024. http://dx.doi.org/10.1109/icsadl61749.2024.00066.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Male, E., H. Liaquat, N. Agrawal, et al. "Non-Alcoholic Fatty Liver Disease in Lung Transplant." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4744.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pivtorak, Kateryna, Olga Yakovleva, and Irina Fedzhaga. "ENDOTHELIAL DYSFUNCTION IN NON-ALCOHOLIC FATTY LIVER DISEASE." In EDUCATION AND SCIENCE OF TODAY: INTERSECTORAL ISSUES AND DEVELOPMENT OF SCIENCES. European Scientific Platform, 2021. http://dx.doi.org/10.36074/logos-29.10.2021.v2.22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chee, Douglas, Darren Tan, Cheng Han Ng, et al. "P10 Population analysis of non-alcoholic fatty liver disease vs alcoholic associated liver disease in liver transplantation." In Abstracts of the British Association for the Study of the Liver Annual Meeting, 19–22 September 2023. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2023. http://dx.doi.org/10.1136/gutjnl-2023-basl.26.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Fatty liver disease"

1

Du, Yuhan, Jiajun Li, Xinchao Huang, and shujing Wu. Association Between Serum Adiponectin And Non-alcoholic Fatty Liver Disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.5.0080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jin, Dachuan, Gao Peng, Shunqin Jin, Tao Zhou, Baoqiang Guo, and Guangming Li. Comparison of therapeutic effects of anti-diabetic drugs on non-alcoholic fatty liver disease patients without diabetes: A network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0014.

Full text
Abstract:
Review question / Objective: To evaluate the efficacy of different anti-diabetic drugs in the treatment of non-diabetic non-alcoholic disease by network meta-analysis, and find the best intervention. Condition being studied: Non-alcoholic fatty liver disease (NAFLD) refers to the disease in which the liver fat content exceeds 5%, and excludes the secondary causes of alcohol, infection, drugs or other specific metabolic diseases. As a spectrum of disorders, it includes hepatocyte steatosis and steatohepatitis at the initial stage, liver fibrosis at the later stage, cirrhosis at the final stage,
APA, Harvard, Vancouver, ISO, and other styles
3

Wang, Shuai, and Xiaoxiao lin. Intermittent fasting for nonalcoholic fatty liver disease (NAFLD): a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.9.0103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wang, Shuai, and Xiaoxiao Lin. Ramadan fasting for nonalcoholic fatty liver disease (NAFLD): a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.9.0102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ismaiel, Abdulrahman, Oana Ciobanu, Mohamed Ismaiel, et al. Atherogenic Index of Plasma in Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.8.0043.

Full text
Abstract:
Review question / Objective: P - Non-alcoholic fatty liver disease (NAFLD) I - Atherogenic index of plasma (AIP) C - Imaging and histopathology O - Mean difference and Area Under the Curve S - Observational studies. Condition being studied: Non-alcoholic fatty liver disease (NAFLD), is a common liver disease characterized by the presence of excessive fat build up within hepatocytes, in the absence of other conditions that result in hepatic steatosis and with little to no alcohol consumption. It refers to a broad range of conditions including steatosis, non-alcoholic steatohepatitis (NASH) and
APA, Harvard, Vancouver, ISO, and other styles
6

Huang, Jinyu, xiaoxiao lin, and jshuai wang. Time-restricted eating for nonalcoholic fatty liver disease (NAFLD): a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.8.0036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cesarini, Lucia, Flavia Grignaffini, Anna Alisi, and Anna Pastore. Alterations in glutathione redox homeostasis in metabolic dysfunction–associated fatty liver disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. http://dx.doi.org/10.37766/inplasy2024.10.0096.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ismaiel, Abdulrahman, Ayman Jaaouani, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, and Dan-Lucian Dumitrascu. The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis — Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.12.0056.

Full text
Abstract:
Review question / Objective: The objective of the study was to compare the mean difference and AUROC of Visceral Adiposity Index (VAI) in NAFLD/NASH/liver fibrosis patients and controls in observational studies. Condition being studied: Nonalcoholic fatty liver disease (NAFLD) is a multi-system disease, being mainly a liver pathology involving excessive hepatic fat accumulation unrelated to alcohol consumption or other secondary causes of hepatic steatosis. It is an emerging cause of concern and increasing clinical burden, imposing a public health challenge. NAFLD is the most common chronic li
APA, Harvard, Vancouver, ISO, and other styles
9

Huang, Shouqiang, Jun Xiong, Jing Ye, and Meihua Liu. Acupuncture for Nonalcoholic fatty liver disease: a systematic review and meta-analysis protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.10.0103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Meng, Zhenzhen. Moxibustion for Nonalcoholic Fatty Liver Disease: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.10.0084.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Fatty liver disease' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography